galantamine and Amentia

galantamine has been researched along with Amentia in 94 studies

Research

Studies (94)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (3.19)	18.2507
2000's	41 (43.62)	29.6817
2010's	43 (45.74)	24.3611
2020's	7 (7.45)	2.80

Authors

Authors	Studies
Bores, GM; Effland, RC; Fink, DM; Huger, FP; Kurys, BE; Rush, DK; Selk, DE	1
Bigg, D; Briley, M; Calmel, F; Carilla, E; Chopin, P; Stenger, A; Vidaluc, JL	1
Chiba, T; Fukuma, K; Ihara, M; Ikeda, S; Kitajima, E; Noda, K; Saito, S; Tanaka, T; Washida, K; Yoshimoto, T	1
Aparasu, RR; Chatterjee, S; Chen, H; Johnson, ML; Masurkar, PP; Sherer, JT	1
Aarsland, D; Andersson, T; Berglund, A; Cummings, J; Freund-Levi, Y; Holmgren, S	1
Achten, E; Beun, S; Clement, P; Moyaert, P	1
Cai, WJ; Chen, KL; Chen, SD; Dong, Q; Feng, L; Giovane, CD; Huang, SY; Huang, YY; Kuo, K; Li, CB; Liu, CY; Shen, XN; Suckling, J; Teng, T; Wang, RZ; Yu, JT; Zhang, C; Zhao, QH; Zhou, XY	1
Barthold, D; Drabo, EF; Ferido, P; Gray, SL; Joyce, G; Marcum, ZA; Zissimopoulos, J	1
Alsabbagh, MW; Huang, Y	1
Goebert, D; Guilloux, A; Higa, J; Lu, BY; Schultz, BR; Takeshita, J; Takeshita, S	1
Bradley, J; Chan, P; Herrmann, N; Lanctôt, K; Mohammad, D	1
Kratz, T	1
Bernal-Cobo, R; Calvo-Torres, LF; Gaviria-Mendoza, A; Machado-Alba, JE; Trujillo-Quintero, PM	1
Johnell, K; Sonde, L	1
Csajka, C; Eap, CB; Ebbing, K; Eyer, S; Giannakopoulos, P; Guidi, M; Noetzli, M; von Gunten, A; Zumbach, S	1
Arizaga, RL; Demey, I; Rojas, G	1
Eriksdotter, M; Freund-Levi, Y; Jedenius, E; Lärksäter, M; Tysen-Bäckström, AC; Wahlund, LO	2
Cumbo, E; Ligori, LD	1
Flores García, JÁ; Tejera Pérez, C	1
Shoji, M	1
Barbosa, MT; Bottino, CM; Caramelli, P; Charchat-Fichman, H; Chaves, ML; Forlenza, OV; Laks, J; Lawson, FL; Machado, JC; Nitrini, R; Palmini, AL; Vale, Fde A	1
Aarsland, D; Auestad, B; Bloniecki, V; Freund-Levi, Y; Lärksäter, M; Tysen Bäckström, AC	1
Fujii, M; Sasaki, H	1
Bogaisky, M	1
Chukhlovina, ML	1
Eichler, T; Hertel, J; Hoffmann, W; Kilimann, I; Michalowsky, B; Teipel, S; Thyrian, JR; Wucherer, D	1
Blazer, D; Reifler, BV	1
Bozoglu, E; Cintosun, U; Doruk, H; Kocak, N; Naharci, MI; Ozturk, A; Tasci, I; Yasar, H	1
Hsieh, CY; Iwata, I; Kao Yang, YH; Lai, EC; Setoguchi, S; Wong, MB; Zhang, Y	1
Huang, AR; Redpath, CJ; van Walraven, C	1
Heinrich, S; Hertel, J; Hoffmann, W; Meyer, S; Michalowsky, B; Schaefer-Walkmann, S; Thyrian, JR; Wübbeler, M; Wucherer, D	1
Chou, YJ; Chow, LH; Hu, HY; Huang, N; Li, CP; Wang, PN; Wu, CY	1
Bogolepova, AN	1
Abagyan, R; Ali, TB; Chen, WY; Reilly, BM; Schleret, TR	1
Lewis, SJ; Szeto, JY	1
Hughes, TL; Iraqi, A	1
Hsieh, CY; Iwata, I; Lai, EC; Setoguchi, S; Wong, MB; Yang, YH; Zhang, Y	1
Cantrell, FL; Pchelnikova, JL; Thornton, SL	1
Isik, AT; Soysal, P	1
Alagiakrishnan, K	1
Dartigues, JF; Fourrier-Réglat, A; Helmer, C; Merliere, Y; Moore, N; Pariente, A	1
Boucher, JM; Charbonneau, C; Dorais, M; LeLorier, J; Lescrauwaet, B; Massoud, F	1
Emelin, AY; Litvinenko, IV; Mogil'naya, VI; Odinak, MM	1
Ishida, T; Kamei, C	1
Frolich, L; Gertz, HJ; Hampel, H; Henn, F; Heuser, I; Hüll, M; Jahn, H; Jessen, F; Kornhuber, J; Luckhaus, C; Maier, W; Pantel, J; Perneczky, R; Peters, O; Rienhoff, O; Rüther, E; Schmidtke, K; Schröder, J; Seuchter, SA; Weih, M; Wiltfang, J; Wolf, S	1
Binder, C; Camacho, F; Dalziel, W; Herrmann, N; Smyth, S	1
Cantor, MD; Farwell, W; Hernandez, RK; Lawler, EV	1
Batrash, A; Obering, C	1
Berlowitz, DR; Brown, J; Budson, AE; Rosenbloom, MH	1
Kremer, J	1
Butler, R; Gupta, S; Warner, JP	1
Clarke, JA; Cutler, M; Dasgupta, M; Freeman, D; Gong, I; Schwarz, UI	1
Anderson, G; Austin, PC; Gill, SS; Gruneir, A; Reimer, CL; Rochon, PA; Seitz, DP	1
Krasakov, IV; Litvinenko, IV; Tikhomirova, OV	1
Howes, MJ; Perry, E	1
Atri, A	1
Gaudig, M; Jedenius, E; Schäuble, B; Wimo, A	1
Fesche, A; Frölich, L; Gertz, HJ; Heuser, I; Hüll, M; Jahn, H; Jessen, F; Kornhuber, J; Lorenz, D; Luckhaus, C; Maier, W; Möller, HJ; Pantel, J; Perneczky, R; Peters, O; Rüther, E; Schmidtke, K; Schröder, J; Teipel, S; Wellek, S	1
Rösler, M	1
Inglis, F	1
Ihl, R	1
Aarsland, D; Hutchinson, M; Larsen, JP	1
Fuchsberger, T; Hampel, H; Möller, HJ	1
Anderson, J; Choudhury, T; Dale, MC; Libretto, SE; McCafferty, F; McWilliam, C; Patterson, C; Richardson, M	1
Bernardi, G; Giordano, A; Koch, G; Marciani, MG; Palmieri, MG; Panella, M; Pierantozzi, M; Stanzione, P; Stefani, A	1
Arya, P; Butler, R; Warner, J	2
Miyanaga, K	1
Ellis, JM	1
Lublin, HK; Olsen, CE; Poulsen, HD	1
Han, SH; Kim, E; Lee, J; Lee, Y	1
Burns, A; Olde Rikkert, MG; Oude Voshaar, RC	1
Lemeshko, ID; Mazal'skaia, OV; Petrukhin, AS; Pylaeva, OA; Voronkova, KV	1
Butler, R; Warner, J; Wuntakal, B	1
Cummings, JL; Ringman, JM	1
Beck, C; Blank, K; Colenda, CC; Doraiswamy, MP; Kalunian, DA; Lyketsos, CG; Yaffe, K	1
Beier, MT	1
Edwards, K; Farlow, M; Hake, A; Hershey, L; Johnson, S; Lichter, D; Pasquier, F; Royall, D	1
Forbes-McKay, KE; McGeown, WJ; Ries, M; Shanks, MF; Venneri, A; Waiter, GD	1
Baker, AS; Brandt, J; Lyketsos, CG; Mayer, LS; McNabney, M; Onyike, CU; Rosenblatt, A; Samus, QM	1
Anghelescu, I; Heuser, I	1
Blair, M; Brashear, R; Davidson, W; Jesso, S; Kertesz, A; Light, M; Morlog, D	1
Landmark, K; Reikvam, A	1
Adelman, A; Campos-Outcalt, D; Cross, JT; Forciea, MA; Hopkins, R; Mehr, D; Owens, DK; Qaseem, A; Santaguida, P; Schellhase, K; Shekelle, P; Snow, V	1
Booker, L; Cowan, D; Ismaila, A; Levine, M; Oremus, M; Patterson, C; Raina, P; Santaguida, P	1
Emelin, AIu; Litvinenko, IV; Mogil'naia, VI; Odinak, MM	1
Liao, S; Morrison, LJ	1
Graham, L	1
Carlezon, WA; Dunn, RW; Fishkin, RJ; Ince, ES	1

Reviews

28 review(s) available for galantamine and Amentia

Article	Year
Effect of Acetylcholinesterase Inhibitors on Cerebral Perfusion and Cognition: A Systematic Review. Journal of Alzheimer's disease : JAD, 2023, Volume: 93, Issue:4 Topics: Acetylcholinesterase; Alzheimer Disease; Cerebrovascular Circulation; Cholinesterase Inhibitors; Cognition; Dementia; Galantamine; Humans; Indans; Parkinson Disease; Perfusion; Phenylcarbamates; Piperidines; Rivastigmine	2023
Pharmacological treatment of neuropsychiatric symptoms of dementia: a network meta-analysis. Age and ageing, 2023, 06-01, Volume: 52, Issue:6 Topics: Aged; Databases, Factual; Dementia; Galantamine; Humans; Network Meta-Analysis; Randomized Controlled Trials as Topic; Risperidone	2023
Comparative risk of cardiac arrhythmias associated with acetylcholinesterase inhibitors used in treatment of dementias - A narrative review. Pharmacology research & perspectives, 2020, Volume: 8, Issue:4 Topics: Alzheimer Disease; Animals; Arrhythmias, Cardiac; Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Humans; Rivastigmine	2020
Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation. Expert opinion on drug safety, 2017, Volume: 16, Issue:9 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Donepezil; Drug Interactions; Galantamine; Humans; Indans; Piperidines; Rivastigmine; Severity of Illness Index	2017
The Diagnosis and Treatment of Behavioral Disorders in Dementia. Deutsches Arzteblatt international, 2017, Jun-30, Volume: 114, Issue:26 Topics: Attention Deficit and Disruptive Behavior Disorders; Cholinesterase Inhibitors; Dementia; Galantamine; Humans; Rivastigmine	2017
Drugs for cognitive loss and dementia. Treatment guidelines from the Medical Letter, 2013, Volume: 11, Issue:134 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Receptors, N-Methyl-D-Aspartate; Rivastigmine	2013
[Programs for continuing medical education: a session; 3. Dementia: diagnosis and therapy]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2014, Mar-10, Volume: 103, Issue:3 Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cholinesterase Inhibitors; Cognitive Dysfunction; Dementia; Disease Progression; Donepezil; Education, Medical, Continuing; Galantamine; Humans; Indans; Lewy Body Disease; Nootropic Agents; Peptide Fragments; Phenylcarbamates; Piperidines; Positron-Emission Tomography; Reference Standards; Rivastigmine; tau Proteins; Tomography, Emission-Computed, Single-Photon	2014
[Pathogenetic mechanisms of dementia in the older patients with Parkinson's diseases]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2014, Volume: 114, Issue:7 Topics: Aging; alpha-Synuclein; Aminoquinolines; Cholinergic Neurons; Cholinesterase Inhibitors; Dementia; Female; Galantamine; Humans; Male; Mutation; Parkinson Disease; Phenylcarbamates; Protein Kinases; Rivastigmine	2014
[A modern concept of mixed dementia]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2015, Volume: 115, Issue:5 Topics: Cognition Disorders; Dementia; Galantamine; Humans	2015
Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia. Current neuropharmacology, 2016, Volume: 14, Issue:4 Topics: Alzheimer Disease; Animals; Antiparkinson Agents; Cholinesterase Inhibitors; Cognitive Behavioral Therapy; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Exercise Therapy; Galantamine; Humans; Indans; Memantine; Parkinson Disease; Piperidines; Rivastigmine; Sleep Wake Disorders; Treatment Outcome	2016
Melatonin based therapies for delirium and dementia. Discovery medicine, 2016, Volume: 21, Issue:117 Topics: Aged; Animals; Antipsychotic Agents; Benzodiazepines; Chronobiology Phenomena; Clinical Trials as Topic; Delirium; Dementia; Drug Therapy, Combination; Galantamine; Humans; Indenes; Melatonin; Memantine; Neuroprotection; Practice Guidelines as Topic	2016
[Cholinesterase inhibitors for treating dementia. Review]. Vertex (Buenos Aires, Argentina), 2010, Volume: 21 Suppl Topics: Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Rivastigmine	2010
Dementia. BMJ clinical evidence, 2010, Apr-08, Volume: 2010 Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Cholinesterase Inhibitors; Dementia; Galantamine; Humans; Memantine	2010
Medicinal plants and dementia therapy: herbal hopes for brain aging? CNS neuroscience & therapeutics, 2011, Volume: 17, Issue:6 Topics: Aged; Behavior; Cognition; Dementia; Galantamine; Ginkgo biloba; Humans; Huperzia; Medicine, Chinese Traditional; Melissa; Panax; Plant Extracts; Plant Preparations; Plants, Medicinal; Primary Prevention; Psychomotor Agitation; Salvia officinalis; Vinca	2011
Effective pharmacological management of Alzheimer's disease. The American journal of managed care, 2011, Volume: 17 Suppl 13 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Dementia; Disease Progression; Donepezil; Galantamine; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine; Time Factors; Treatment Outcome	2011
The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia. International journal of clinical practice. Supplement, 2002, Issue:127 Topics: Behavioral Symptoms; Carbamates; Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Humans; Indans; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; Treatment Outcome	2002
The tolerability and safety of cholinesterase inhibitors in the treatment of dementia. International journal of clinical practice. Supplement, 2002, Issue:127 Topics: Carbamates; Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Humans; Indans; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine	2002
[Current therapy of patients with dementia]. MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2 Topics: Activities of Daily Living; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Controlled Clinical Trials as Topic; Dementia; Dementia, Vascular; Donepezil; Dopamine Agents; Female; Galantamine; Ginkgo biloba; Humans; Indans; Male; Memantine; Meta-Analysis as Topic; Multicenter Studies as Topic; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Phytotherapy; Piperidines; Placebos; Plant Preparations; Prospective Studies; Rivastigmine; Tacrine; Time Factors	2003
Dementia. Clinical evidence, 2004, Issue:11 Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cognition; Dementia; Donepezil; Galantamine; Ginkgo biloba; Haloperidol; Humans; Indans; Memantine; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Risperidone; Rivastigmine; Selegiline; Tacrine; Vitamin E	2004
Cholinesterase inhibitors in the treatment of dementia. The Journal of the American Osteopathic Association, 2005, Volume: 105, Issue:3 Topics: Acetylcholine; Acetylcholinesterase; Aged; Alzheimer Disease; Cholinesterase Inhibitors; Cost of Illness; Dementia; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Severity of Illness Index	2005
Dementia. Clinical evidence, 2004, Issue:12 Topics: Alzheimer Disease; Dementia; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Rivastigmine; Tacrine	2004
Drug therapy of dementia in elderly patients. A review. Nordic journal of psychiatry, 2005, Volume: 59, Issue:2 Topics: Aged; Alzheimer Disease; Dementia; Donepezil; Galantamine; Humans; Indans; Memantine; Neuroprotective Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine	2005
Dementia. Clinical evidence, 2005, Issue:14 Topics: Alzheimer Disease; Benzodiazepines; Dementia; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Memantine; Nootropic Agents; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Rivastigmine; Selegiline; Tacrine	2005
Current and emerging pharmacological treatment options for dementia. Behavioural neurology, 2006, Volume: 17, Issue:1 Topics: Acetylcholine; Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Humans; Indans; Lewy Body Disease; Neurodegenerative Diseases; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine	2006
Harmless herbs? Think again: merits of a complete medication history. Journal of the American Medical Directors Association, 2006, Volume: 7, Issue:7 Topics: Aged; Alkaloids; Cholinesterase Inhibitors; Dementia; Evidence-Based Medicine; Galantamine; Geriatric Assessment; Geriatrics; Ginkgo biloba; Herb-Drug Interactions; Humans; Medical History Taking; Neuroprotective Agents; Nootropic Agents; Phytotherapy; Sesquiterpenes	2006
[Acetylcholinesterase inhibitors for dementia--an update]. MMW Fortschritte der Medizin, 2007, May-21, Volume: 149 Suppl 2 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Clinical Trials as Topic; Dementia; Donepezil; Galantamine; Humans; Indans; Lewy Body Disease; Multicenter Studies as Topic; Neuroprotective Agents; Nootropic Agents; Parkinson Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Time Factors	2007
[Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2008, Jan-31, Volume: 128, Issue:3 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Dementia, Vascular; Donepezil; Evidence-Based Medicine; Galantamine; Humans; Indans; Lewy Body Disease; Phenylcarbamates; Piperidines; Rivastigmine; Time Factors; Treatment Outcome	2008
Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Annals of internal medicine, 2008, Mar-04, Volume: 148, Issue:5 Topics: Activities of Daily Living; Affect; Cholinesterase Inhibitors; Cognition; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Quality of Life; Rivastigmine; Tacrine	2008

Trials

12 trial(s) available for galantamine and Amentia

Article	Year
Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2014, Volume: 22, Issue:4 Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Cholinesterase Inhibitors; Dementia; Female; Galantamine; Humans; Irritable Mood; Male; Neuropsychological Tests; Psychomotor Agitation; Risperidone; Treatment Outcome	2014
Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial. Journal of Alzheimer's disease : JAD, 2014, Volume: 39, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Behavioral Symptoms; Cholinesterase Inhibitors; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Female; Galantamine; Humans; Indans; Longitudinal Studies; Male; Memantine; Mental Disorders; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Rivastigmine	2014
Effects of galantamine and galantamine combined with nimodipine on cognitive speed and quality of life in mixed dementia: a 24-week, randomized, placebo-controlled exploratory trial (the REMIX study). Arquivos de neuro-psiquiatria, 2014, Volume: 72, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebrovascular Disorders; Cholinesterase Inhibitors; Cognition; Dementia; Double-Blind Method; Drug Therapy, Combination; Female; Galantamine; Humans; Male; Neuropsychological Tests; Nimodipine; Quality of Life; Surveys and Questionnaires; Time Factors; Treatment Outcome; Vasodilator Agents	2014
Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study. Dementia and geriatric cognitive disorders, 2014, Volume: 38, Issue:3-4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Dementia; Dementia, Vascular; Female; Galantamine; Humans; Male; Nootropic Agents; Psychomotor Agitation; Risperidone; Treatment Outcome	2014
Antidementia drug treatment in people screened positive for dementia in primary care. Journal of Alzheimer's disease : JAD, 2015, Volume: 44, Issue:3 Topics: Aged; Aged, 80 and over; Dementia; Donepezil; Female; Galantamine; Humans; Indans; Male; Memantine; Mental Status Schedule; Neuropsychological Tests; Nootropic Agents; Phenylcarbamates; Piperidines; Primary Health Care; Rivastigmine	2015
Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson's disease (an open controlled trial). Neuroscience and behavioral physiology, 2008, Volume: 38, Issue:9 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Caregivers; Cholinesterase Inhibitors; Cognition; Dementia; Family; Galantamine; Humans; Mental Status Schedule; Middle Aged; Motor Activity; Parkinson Disease; Severity of Illness Index; Time Factors	2008
The economic impact of galantamine vs placebo: an analysis based on functional capacity in a Swedish cohort study. Journal of medical economics, 2012, Volume: 15, Issue:5 Topics: Activities of Daily Living; Cohort Studies; Dementia; Double-Blind Method; Galantamine; Health Care Costs; Humans; Longitudinal Studies; Nootropic Agents; Regression Analysis; Sweden	2012
A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI. The journal of nutrition, health & aging, 2012, Volume: 16, Issue:6 Topics: Aged; Alzheimer Disease; Amnesia; Cholinesterase Inhibitors; Cognition; Cognitive Dysfunction; Cohort Studies; Dementia; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Early Termination of Clinical Trials; Female; Galantamine; Germany; Humans; Male; Memantine; Middle Aged; Nootropic Agents; Psychiatric Status Rating Scales; Receptors, N-Methyl-D-Aspartate	2012
Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia. International journal of geriatric psychiatry, 2003, Volume: 18, Issue:10 Topics: Aged; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Female; Galantamine; Hallucinations; Humans; Male; Mental Status Schedule; Nootropic Agents; Parkinson Disease; Treatment Outcome	2003
Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study. Dementia and geriatric cognitive disorders, 2007, Volume: 23, Issue:6 Topics: Aged; Aged, 80 and over; Behavioral Symptoms; Cholinesterase Inhibitors; Dementia; Dose-Response Relationship, Drug; Female; Galantamine; Hallucinations; Humans; Lewy Body Disease; Male; Mental Status Schedule; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinsonian Disorders; Treatment Outcome	2007
Galantamine in frontotemporal dementia and primary progressive aphasia. Dementia and geriatric cognitive disorders, 2008, Volume: 25, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Aphasia, Primary Progressive; Cholinesterase Inhibitors; Dementia; Double-Blind Method; Female; Galantamine; Humans; Male; Middle Aged; Neuropsychological Tests; Severity of Illness Index	2008
[Efficacy and safety of galantamine (reminyl) in the treatment of dementia in patients with Parkinson's disease (open-label controlled trial)]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2007, Volume: 107, Issue:12 Topics: Aged; Cognition; Dementia; Dose-Response Relationship, Drug; Follow-Up Studies; Galantamine; Humans; Motor Activity; Nootropic Agents; Parkinson Disease; Quality of Life; Severity of Illness Index; Time Factors; Treatment Outcome	2007

Other Studies

54 other study(ies) available for galantamine and Amentia

Article	Year
Synthesis and evaluation of 5-amino-5,6,7,8-tetrahydroquinolinones as potential agents for the treatment of Alzheimer's disease. Journal of medicinal chemistry, 1995, Sep-01, Volume: 38, Issue:18 Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Aminoquinolines; Animals; Cholinesterase Inhibitors; Dementia; Drug Evaluation; Male; Mice; Rats; Scopolamine; Sesquiterpenes; Structure-Activity Relationship	1995
Novel [2-(4-piperidinyl)ethyl](thio)ureas: synthesis and antiacetylcholinesterase activity. Journal of medicinal chemistry, 1994, Mar-04, Volume: 37, Issue:5 Topics: Acetylcholinesterase; Amnesia; Animals; Avoidance Learning; Cholinesterase Inhibitors; Dementia; Dose-Response Relationship, Drug; Hydrogen Bonding; Mice; Molecular Conformation; Molecular Structure; Piperidines; Rats; Scopolamine; Structure-Activity Relationship; Thiourea	1994
A Nationwide Multi-Center Questionnaire Survey on the Real-World State and Clinical Management of Poststroke Dementia in Japan. Journal of Alzheimer's disease : JAD, 2021, Volume: 84, Issue:3 Topics: Aged; Cognitive Dysfunction; Cross-Sectional Studies; Dementia; Donepezil; Female; Galantamine; Humans; Japan; Male; Memantine; Mental Status and Dementia Tests; Stroke; Surveys and Questionnaires	2021
Risk of overactive bladder associated with cholinesterase inhibitors in dementia. Journal of the American Geriatrics Society, 2022, Volume: 70, Issue:3 Topics: Aged; Cholinesterase Inhibitors; Dementia; Donepezil; Female; Galantamine; Humans; Male; Medicare; Muscarinic Antagonists; Retrospective Studies; Rivastigmine; United States; Urinary Bladder, Overactive	2022
Neuropsychiatric Symptoms in Dementia: Considering a Clinical Role for Electroencephalography. The Journal of neuropsychiatry and clinical neurosciences, 2022,Summer, Volume: 34, Issue:3 Topics: Alzheimer Disease; Dementia; Electroencephalography; Galantamine; Humans; Neuropsychological Tests; Risperidone	2022
Pharmaceutical Treatment for Alzheimer's Disease and Related Dementias: Utilization and Disparities. Journal of Alzheimer's disease : JAD, 2020, Volume: 76, Issue:2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Donepezil; Dopamine Agents; Female; Galantamine; Healthcare Disparities; Humans; Male; Medicare; Memantine; Nootropic Agents; Patient Acceptance of Health Care; Rivastigmine; Treatment Outcome; United States	2020
Simultaneous usage of dementia medications and anticholinergics among Asians and Pacific Islanders. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2017, Volume: 17, Issue:6 Topics: Aged; Aged, 80 and over; Asian People; Cholinergic Antagonists; Cholinesterase Inhibitors; Dementia; Donepezil; Female; Galantamine; Hawaii; Hospitals, Urban; Humans; Indans; Male; Memantine; Native Hawaiian or Other Pacific Islander; Pacific Islands; Piperidines; Retrospective Studies; Rivastigmine	2017
[Patterns of antidemential drug use in a group of patients from Colombia]. Revista de neurologia, 2019, May-16, Volume: 68, Issue:10 Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Colombia; Cross-Sectional Studies; Dementia; Donepezil; Drug Utilization; Female; Galantamine; Humans; Male; Memantine; Middle Aged; Receptors, N-Methyl-D-Aspartate; Rivastigmine	2019
Is drug treatment for dementia followed up in primary care? A Swedish study of dementia clinics and referring primary care centres. PloS one, 2013, Volume: 8, Issue:2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Dementia, Vascular; Donepezil; Female; Galantamine; Humans; Indans; Male; Medical Records; Memantine; Nootropic Agents; Phenylcarbamates; Piperidines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Primary Health Care; Retrospective Studies; Rivastigmine; Sweden; Treatment Outcome	2013
Relationship of CYP2D6, CYP3A, POR, and ABCB1 genotypes with galantamine plasma concentrations. Therapeutic drug monitoring, 2013, Volume: 35, Issue:2 Topics: Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cholinesterase Inhibitors; Cohort Studies; Cross-Sectional Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Dementia; Female; Galantamine; Genotype; Humans; Male; NADPH-Ferrihemoprotein Reductase	2013
[Drugs used for cognitive impairment. Analysis of 1.5 million prescriptions in Argentina]. Medicina, 2013, Volume: 73, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Argentina; Child; Child, Preschool; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Dementia, Vascular; Donepezil; Drug Prescriptions; Female; Galantamine; Humans; Indans; Infant; Male; Memantine; Middle Aged; Phenylcarbamates; Piperidines; Retrospective Studies; Rivastigmine; Young Adult	2013
[Dementia solved with surgery: report of a case]. Medicina clinica, 2015, Jan-20, Volume: 144, Issue:2 Topics: Alzheimer Disease; Consciousness Disorders; Delayed Diagnosis; Dementia; Diagnostic Errors; Diagnostic Imaging; False Negative Reactions; Female; Galantamine; Humans; Hyperinsulinism; Hypoglycemia; Insulinoma; Middle Aged; Nootropic Agents; Pancreatectomy; Pancreatic Neoplasms; Remission Induction; Weight Gain	2015
Anti-dementia drugs in a psychiatric hospital for dementia patients. Geriatrics & gerontology international, 2014, Volume: 14, Issue:3 Topics: Aged; Dementia; Donepezil; Galantamine; Hospitalization; Hospitals, Psychiatric; Humans; Indans; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine	2014
Response to Bogaiksy's letter to the editor. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2014, Volume: 22, Issue:9 Topics: Antipsychotic Agents; Cholinesterase Inhibitors; Dementia; Female; Galantamine; Humans; Irritable Mood; Male; Psychomotor Agitation; Risperidone	2014
Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2014, Volume: 22, Issue:9 Topics: Antipsychotic Agents; Cholinesterase Inhibitors; Dementia; Female; Galantamine; Humans; Irritable Mood; Male; Psychomotor Agitation; Risperidone	2014
An unsubstantiated conclusion. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2015, Volume: 23, Issue:2 Topics: Antipsychotic Agents; Cholinesterase Inhibitors; Dementia; Female; Galantamine; Humans; Irritable Mood; Male; Psychomotor Agitation; Risperidone	2015
Galantamine improves sleep quality in patients with dementia. Acta neurologica Belgica, 2015, Volume: 115, Issue:4 Topics: Aged; Aged, 80 and over; Chi-Square Distribution; Cholinesterase Inhibitors; Dementia; Donepezil; Dose-Response Relationship, Drug; Female; Galantamine; Humans; Indans; Male; Piperidines; Rivastigmine; Severity of Illness Index; Sleep Wake Disorders; Treatment Outcome	2015
Risk of pneumonia in new users of cholinesterase inhibitors for dementia. Journal of the American Geriatrics Society, 2015, Volume: 63, Issue:5 Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Cohort Studies; Dementia; Donepezil; Female; Galantamine; Humans; Indans; Male; Phenylcarbamates; Piperidines; Pneumonia; Retrospective Studies; Risk Assessment; Rivastigmine	2015
The influence of cholinesterase inhibitor therapy for dementia on risk of cardiac pacemaker insertion: a retrospective, population-based, health administrative databases study in Ontario, Canada. BMC neurology, 2015, Apr-28, Volume: 15 Topics: Aged; Cholinesterase Inhibitors; Comorbidity; Databases, Factual; Dementia; Donepezil; Female; Galantamine; Health Services Research; Humans; Indans; Male; Ontario; Pacemaker, Artificial; Piperidines; Prosthesis Implantation; Retrospective Studies; Risk; Rivastigmine	2015
Antidementia drug treatment in dementia networks in Germany: use rates and factors associated with treatment use. BMC health services research, 2015, May-22, Volume: 15 Topics: Aged; Aged, 80 and over; Caregivers; Cholinesterase Inhibitors; Dementia; Donepezil; Dopamine Agents; Female; Galantamine; Germany; Humans; Indans; Interviews as Topic; Logistic Models; Male; Memantine; Neuroprotective Agents; Nootropic Agents; Piperidines; Rivastigmine	2015
The Effects of Anti-Dementia and Nootropic Treatments on the Mortality of Patients with Dementia: A Population-Based Cohort Study in Taiwan. PloS one, 2015, Volume: 10, Issue:6 Topics: Cohort Studies; Dementia; Dihydroergocristine; Dihydroergotamine; Donepezil; Galantamine; Humans; Indans; Memantine; Neuroprotective Agents; Nootropic Agents; Piperidines; Piracetam; Proportional Hazards Models; Retrospective Studies; Rivastigmine; Taiwan; Time Factors	2015
Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada. PloS one, 2015, Volume: 10, Issue:12 Topics: Adverse Drug Reaction Reporting Systems; Alzheimer Disease; Canada; Cholinesterase Inhibitors; Databases, Factual; Dementia; Donepezil; Galantamine; Humans; Indans; Pharmacovigilance; Piperidines; Rivastigmine; United States; United States Food and Drug Administration	2015
Pneumonia Risk with Cholinesterase Inhibitors. Journal of the American Geriatrics Society, 2016, Volume: 64, Issue:1 Topics: Cholinesterase Inhibitors; Dementia; Female; Galantamine; Humans; Indans; Male; Phenylcarbamates; Piperidines; Pneumonia	2016
Response to Iraqi and Hughes. Journal of the American Geriatrics Society, 2016, Volume: 64, Issue:1 Topics: Cholinesterase Inhibitors; Dementia; Female; Galantamine; Humans; Indans; Male; Phenylcarbamates; Piperidines; Pneumonia	2016
Characteristics of Pediatric Exposures to Antidementia Drugs Reported to a Poison Control System. The Journal of pediatrics, 2016, Volume: 172 Topics: Child; Child, Preschool; Dementia; Donepezil; Female; Galantamine; Humans; Indans; Infant; Male; Memantine; Nootropic Agents; Piperidines; Poison Control Centers; Retrospective Studies; Rivastigmine	2016
Effects of Acetylcholinesterase Inhibitors on Nutritional Status in Elderly Patients with Dementia: A 6-month Follow-up Study. The journal of nutrition, health & aging, 2016, Volume: 20, Issue:4 Topics: Acetylcholinesterase; Activities of Daily Living; Aged; Body Mass Index; Body Weight; Cholinesterase Inhibitors; Dementia; Disease Progression; Donepezil; Eating; Female; Follow-Up Studies; Galantamine; Geriatric Assessment; Humans; Indans; Male; Nutrition Assessment; Nutritional Status; Piperidines; Polypharmacy; Retrospective Studies; Rivastigmine	2016
Prevalence of cholinesterase inhibitors in subjects with dementia in Europe. Pharmacoepidemiology and drug safety, 2008, Volume: 17, Issue:7 Topics: Cholinesterase Inhibitors; Dementia; Donepezil; Europe; Galantamine; Health Policy; Humans; Indans; Insurance, Health, Reimbursement; Phenylcarbamates; Piperidines; Practice Patterns, Physicians'; Prevalence; Rivastigmine	2008
Drug utilization review of cholinesterase inhibitors in Quebec. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2008, Volume: 35, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Dementia; Donepezil; Drug Utilization Review; Galantamine; Humans; Indans; Middle Aged; Phenylcarbamates; Piperidines; Quebec; Rivastigmine	2008
Characteristic effects of anti-dementia drugs on rat sleep patterns. Journal of pharmacological sciences, 2009, Volume: 109, Issue:3 Topics: Animals; Dementia; Donepezil; Dose-Response Relationship, Drug; Electroencephalography; Electromyography; Excitatory Amino Acid Antagonists; Galantamine; Indans; Male; Memantine; Nootropic Agents; Piperidines; Rats; Rats, Wistar; Sleep; Sleep Wake Disorders; Sleep, REM	2009
Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence Network. Dementia and geriatric cognitive disorders, 2009, Volume: 27, Issue:5 Topics: Aged; Cognition Disorders; Cohort Studies; Cross-Sectional Studies; Databases, Factual; Dementia; Diagnosis, Differential; Female; Galantamine; Germany; Humans; Magnetic Resonance Imaging; Male; Memantine; Middle Aged; Multicenter Studies as Topic; Nootropic Agents; Phenotype; Quality Control; Tomography, X-Ray Computed	2009
Persistence with cholinesterase inhibitor therapy for dementia: an observational administrative health database study. Drugs & aging, 2009, Volume: 26, Issue:5 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Databases, Factual; Delayed-Action Preparations; Dementia; Donepezil; Follow-Up Studies; Galantamine; Humans; Indans; Medication Adherence; Phenylcarbamates; Piperidines; Rivastigmine	2009
Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system. Journal of the American Geriatrics Society, 2009, Volume: 57, Issue:11 Topics: Alzheimer Disease; Bradycardia; Cholinesterase Inhibitors; Cross-Sectional Studies; Dementia; Donepezil; Dose-Response Relationship, Drug; Drug Therapy, Combination; Galantamine; Heart Rate; Hospitals, Veterans; Humans; Incidence; Indans; Massachusetts; Nootropic Agents; Phenylcarbamates; Piperidines; Risk; Rivastigmine; Veterans	2009
Case report: combined use of donepezil and galantamine in mixed dementia. Journal of the American Geriatrics Society, 2009, Volume: 57, Issue:10 Topics: Aged, 80 and over; Cholinesterase Inhibitors; Dementia; Donepezil; Drug Therapy, Combination; Galantamine; Humans; Indans; Male; Piperidines	2009
Safety and tolerability of galantamine SA in dementia patients transitioned from donepezil. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2011, Volume: 26, Issue:2 Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Humans; Indans; Middle Aged; Piperidines; Retrospective Studies	2011
Cytochrome P450 2D6 phenotyping in an elderly population with dementia and response to galantamine in dementia: a pilot study. The American journal of geriatric pharmacotherapy, 2011, Volume: 9, Issue:4 Topics: Aged; Aged, 80 and over; Case-Control Studies; Cholinesterase Inhibitors; Cytochrome P-450 CYP2D6; Dementia; Female; Galantamine; Humans; Male; Middle Aged; Phenotype; Pilot Projects; Treatment Outcome	2011
Effects of cholinesterase inhibitors on postoperative outcomes of older adults with dementia undergoing hip fracture surgery. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2011, Volume: 19, Issue:9 Topics: Aged; Aged, 80 and over; Anesthesia, General; Cholinesterase Inhibitors; Cohort Studies; Critical Care; Dementia; Donepezil; Female; Galantamine; Hip Fractures; Humans; Indans; Male; Outcome and Process Assessment, Health Care; Phenylcarbamates; Piperidines; Pneumonia; Postoperative Complications; Respiratory Insufficiency; Resuscitation; Risk; Rivastigmine	2011
[Sleep disorders in patients with dementia in Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2011, Volume: 111, Issue:9 Topics: Aged; Dementia; Female; Galantamine; Humans; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Sleep Wake Disorders; Sleep, REM	2011
The impact of drugs against dementia on cognition in aging and mild cognitive impairment. Pharmacopsychiatry, 2003, Volume: 36 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Aging; Cognition; Cognition Disorders; Dementia; Donepezil; Female; Galantamine; Ginkgo biloba; Humans; Indans; Male; MEDLINE; Middle Aged; Nootropic Agents; Piperidines; Plant Extracts	2003
Clinical experience of galantamine in dementia: a series of case reports. Current medical research and opinion, 2003, Volume: 19, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Female; Galantamine; Humans; Male; Middle Aged; Nootropic Agents	2003
Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2004, Volume: 115, Issue:10 Topics: Aged; Alzheimer Disease; Brain; Cholinesterase Inhibitors; Dementia; Electromagnetic Fields; Electromyography; Evoked Potentials, Motor; Female; Frontal Lobe; Functional Laterality; Galantamine; Humans; Male; Middle Aged; Neuroprotective Agents; Temporal Lobe	2004
[Treatment of dementia]. Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 2005, Volume: 42, Issue:1 Topics: Cerebrovascular Circulation; Cholinesterase Inhibitors; Dementia; Exercise; Galantamine; Humans; Nutritional Support; Receptors, Neurotransmitter; Tacrine	2005
Galantamine: excess mortality. Prescrire international, 2005, Volume: 14, Issue:77 Topics: Cholinesterase Inhibitors; Clinical Trials as Topic; Dementia; France; Galantamine; Humans; Indans; Mortality; Piperidines; Treatment Outcome	2005
A case with cholinesterase inhibitor responsive asymmetric posterior cortical atrophy. Clinical neurology and neurosurgery, 2005, Volume: 108, Issue:1 Topics: Apraxias; Cholinesterase Inhibitors; Dementia; Female; Galantamine; Humans; Middle Aged; Perceptual Disorders	2005
Alarming arbitrariness in EU prescription and reimbursement criteria for anti-dementia drugs. International journal of geriatric psychiatry, 2006, Volume: 21, Issue:1 Topics: Cholinesterase Inhibitors; Dementia; Donepezil; Dopamine Agents; European Union; Galantamine; Humans; Indans; Memantine; Neurotransmitter Agents; Phenylcarbamates; Piperidines; Reimbursement Mechanisms; Rivastigmine	2006
[Use of reminyl (galantamine) in the treatment of dementia]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2006, Volume: 106, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Dementia, Vascular; Female; Galantamine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome	2006
Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2006, Volume: 14, Issue:7 Topics: Aged; Alkaloids; Alzheimer Disease; Brain; Caregivers; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Diagnostic and Statistical Manual of Mental Disorders; Galantamine; Geriatric Psychiatry; Health Services for the Aged; Humans; Phenylcarbamates; Professional-Family Relations; Rivastigmine; Sesquiterpenes; Tacrine; United States	2006
Regional brain activity after prolonged cholinergic enhancement in early Alzheimer's disease. Magnetic resonance imaging, 2007, Volume: 25, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Cholinergic Agents; Dementia; Female; Galantamine; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Parasympathomimetics; Reproducibility of Results	2007
Acetylcholinesterase inhibitors in assisted living: patterns of use and association with retention. International journal of geriatric psychiatry, 2008, Volume: 23, Issue:2 Topics: Activities of Daily Living; Aged, 80 and over; Alzheimer Disease; Assisted Living Facilities; Cholinesterase Inhibitors; Dementia; Donepezil; Drug Administration Schedule; Female; Galantamine; Health Surveys; Homes for the Aged; Humans; Indans; Male; Mental Status Schedule; Neuropsychological Tests; Phenylcarbamates; Piperidines; Retention, Psychology; Rivastigmine; Survival Analysis; Treatment Outcome	2008
Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease. Prescrire international, 2007, Volume: 16, Issue:91 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Dystonia; France; Galantamine; Humans; Indans; Lewy Body Disease; Parkinson Disease; Phenylcarbamates; Piperidines; Tremor	2007
Summaries for patients. Drug treatment for patients with dementia: American College of Physicians and American Academy of Family Physicians recommendations. Annals of internal medicine, 2008, Mar-04, Volume: 148, Issue:5 Topics: Activities of Daily Living; Affect; Cholinesterase Inhibitors; Cognition; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Quality of Life; Rivastigmine; Tacrine	2008
Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Annals of internal medicine, 2008, Mar-04, Volume: 148, Issue:5 Topics: Activities of Daily Living; Affect; Cholinesterase Inhibitors; Cognition; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Quality of Life; Rivastigmine; Tacrine	2008
Dementia medications in palliative care #174. Journal of palliative medicine, 2008, Volume: 11, Issue:4 Topics: Antiparkinson Agents; Cholinesterase Inhibitors; Dementia; Disease Progression; Donepezil; Galantamine; Humans; Indans; Memantine; Neuroprotective Agents; Nootropic Agents; Palliative Care; Phenylcarbamates; Piperidines; Prognosis; Receptors, N-Methyl-D-Aspartate; Rivastigmine	2008
AAFP and ACP release guideline on dementia treatment. American family physician, 2008, Apr-15, Volume: 77, Issue:8 Topics: Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Guidelines as Topic; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine	2008
D-cycloserine attenuates scopolamine-induced learning and memory deficits in rats. Behavioral and neural biology, 1993, Volume: 59, Issue:2 Topics: Animals; Behavior, Animal; Cycloserine; Dementia; Galantamine; Learning; Learning Disabilities; Male; Memory; Rats; Rats, Wistar; Scopolamine Derivatives; Space Perception	1993